This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.
Presenter: T.M., Suszynski, Minneapolis, USA
Authors: T.M. Suszynski, E.S. Avgoustiniatos, S.A. Stein, E.J. Falde, B.E. Hammer, K.K. Papas
Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy
T.M. Suszynski1, E.S. Avgoustiniatos1, S.A. Stein1, E.J. Falde1, B.E. Hammer2, K.K. Papas1
1 University of Minnesota, Department of Surgery, Minneapolis, MN, USA; 2 University of Minnesota, Department of Radiology, Minneapolis, MN, USA
Objective: To evaluate whether fluorine magnetic resonance spectroscopy (19F-MRS) can be used to assess tissue-engineered islet graft viability by non-invasively measuring pO2 and estimating islet oxygen consumption rate (OCR).
Methods: Scaffolds composed of porcine plasma were seeded with human islets and perfluorodecalin and each gel was covered with the similar volumes of culture media in Petri dishes (Figure 1).
Figure 1: Schematic of tissue-engineered scaffold.
Four different scaffolds were seeded with varying numbers (0-8000) of islet equivalents (IE), aliquoted from the same islet preparation. Run order was randomized and scaffolds were examined by19F-MRS at 37°C using a 5T spectrometer and a single-loop surface coil placed underneath each scaffold. A standard inversion recovery sequence was used to obtain a characteristic19F spin-lattice relaxation time (T1), which was converted to a steady-state average pO2 estimate using a previously determined linear calibration (pO2 (mm Hg) = 5.26·105/T1 (ms) – 122; R2 = 0.985). Each condition was assessed in replicate (n = 6-8).
Results: Scaffolds exhibited an IE dose-dependent increase in T1 and decrease in pO2 estimates (Table 1).
Table 1: T1 values (mean ± SEM) and pO2 estimates for scaffolds seeded with varying numbers of human IE |
||
IE per Scaffold |
T1 Measured (ms) |
pO2 Estimate (mm Hg) |
0 |
1866 ± 7 |
160 |
2000 |
1942 ± 9 |
149 |
4000 |
2081 ± 11 |
131 |
8000 |
2181 ± 15 |
119 |
From the difference between pO2 estimates and ambient pO2 (ΔpO2), we calculated the islet preparation OCR to be 93 ± 10 (mean ± SEM) nmol/(min∙mg DNA) using theoretical modeling. This value compares well with OCR values measured with established methods for human islet preparations.
Conclusions:19F-MRS can be used for the non-invasive pre- and possibly post-transplant assessment of tissue-engineered islet graft viability by estimating the amount of viable, oxygen-consuming tissue remaining in a scaffold.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada